318 filings
Page 4 of 16
8-K
wkiuwo97wj y5
14 Jul 17
Departure of Directors or Certain Officers
12:00am
424B5
t5jx51qsrixg5l69p6p
19 Jun 17
Prospectus supplement for primary offering
12:00am
8-K
rnrm8imkn5d5x4 li4
19 Jun 17
Entry into a Material Definitive Agreement
12:00am
424B5
lyqowyuwif oms7u0h2x
19 Jun 17
Prospectus supplement for primary offering
12:00am
AW WD
p0c xemg2fx0kvfeuc
9 Jun 17
Withdrawal of amendment withdrawal request
12:00am
AW
4ne9n3y7t034f jhvsw7
9 Jun 17
Withdrawal of amendment
12:00am
S-8 POS
ypvfy4gwak6qk
9 Jun 17
Registration of securities for employees (post-effective amendment)
12:00am
AW
fvoyel42fz
8 Jun 17
Withdrawal of amendment
12:00am
POS AM
9f44g54j
5 Jun 17
Prospectus update (post-effective amendment)
12:00am
S-8
kj0ms6kqs3d
1 Jun 17
Registration of securities for employees
12:00am
8-K
3s980kgm7qy7amxmkh4
25 May 17
Other Events
12:00am
8-K
4uiypx8ymoff f2dy6c
18 May 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
n3pco8n
10 May 17
Anthera Pharmaceuticals Provides Business Update
12:00am
8-K
kd00rr 9sr9z7fs
28 Apr 17
Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock
12:00am
8-K
9xd9o8isgllhmmjqfqus
27 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K
52lvsk9va3m
31 Mar 17
Anthera Announces Positive Results from the Extension Period of the SOLUTION Study of Sollpura
12:00am
8-K
z5lht9
16 Mar 17
Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants
12:00am
DEFA14A
bsrgeju
16 Mar 17
Additional proxy soliciting materials
12:00am